152 related articles for article (PubMed ID: 19876600)
1. Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination.
Passarin MG; Moretto G; Musso AM; Ottaviani S; Masotto B; Ghimenton C; Iuzzolino P; Buffone E; Rudà R; Soffietti R; Vattemi E; Pedersini R
J Neurooncol; 2010 May; 97(3):439-44. PubMed ID: 19876600
[TBL] [Abstract][Full Text] [Related]
2. Neoplastic meningitis from breast cancer: feasibility and activity of long-term intrathecal liposomal Ara-C combined with dose-dense temozolomide.
Hoffmann AL; Buhk JH; Strik H
Anticancer Res; 2009 Dec; 29(12):5191-5. PubMed ID: 20044635
[TBL] [Abstract][Full Text] [Related]
3. Leptomeningeal melanomatosis: stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine.
Schaefer N; Rasch K; Moehlenbruch M; Urbach H; Stuplich M; Blasius E; Scheffler B; Herrlinger U; Glas M
Acta Oncol; 2011 Nov; 50(8):1260-2. PubMed ID: 21736503
[No Abstract] [Full Text] [Related]
4. Primary leptomeningeal anaplastic oligodendroglioma with a 1p36-19q13 deletion: report of a unique case successfully treated with Temozolomide.
Michotte A; Chaskis C; Sadones J; Veld PI; Neyns B
J Neurol Sci; 2009 Dec; 287(1-2):267-70. PubMed ID: 19751941
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal liposomal cytarabine and leptomeningeal medulloblastoma relapse: a valuable therapeutic option.
Mastronuzzi A; Del Bufalo F; Iacono A; Secco DE; Serra A; Colafati GS; DE Ioris MA; Corsetti T
Anticancer Res; 2013 Aug; 33(8):3515-8. PubMed ID: 23898128
[TBL] [Abstract][Full Text] [Related]
6. Temozolomide chemotherapy in recurrent oligodendroglioma.
van den Bent MJ; Keime-Guibert F; Brandes AA; Taphoorn MJ; Kros JM; Eskens FA; Carpentier AF
Neurology; 2001 Jul; 57(2):340-2. PubMed ID: 11468326
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas.
Brada M; Viviers L; Abson C; Hines F; Britton J; Ashley S; Sardell S; Traish D; Gonsalves A; Wilkins P; Westbury C
Ann Oncol; 2003 Dec; 14(12):1715-21. PubMed ID: 14630674
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of intracranial ependymoma with leptomeningeal spread with systemic chemotherapy and intrathecal liposomal cytarabine in a two-year-old child.
Lassaletta A; Perez-Olleros P; Scaglione C; Sirvent S; De Prada I; Perez-Martinez A; Ruiz-Hernandez A; Madero L
J Neurooncol; 2007 Jul; 83(3):303-6. PubMed ID: 17245619
[TBL] [Abstract][Full Text] [Related]
9. Temozolomide and cisplatin in the treatment of leptomeningeal metastatic involvement from melanoma: a case report.
Salmaggi A; Silvani A; Eoli M; Lamperti E; Boiardi A
Neurol Sci; 2002 Dec; 23(5):257-8. PubMed ID: 12528690
[No Abstract] [Full Text] [Related]
10. Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study.
Guillaume DJ; Doolittle ND; Gahramanov S; Hedrick NA; Delashaw JB; Neuwelt EA
Neurosurgery; 2010 Jan; 66(1):48-58; discussion 58. PubMed ID: 20023537
[TBL] [Abstract][Full Text] [Related]
11. Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas.
Triebels VH; Taphoorn MJ; Brandes AA; Menten J; Frenay M; Tosoni A; Kros JM; Stege EB; Enting RH; Allgeier A; van Heuvel I; van den Bent MJ
Neurology; 2004 Sep; 63(5):904-6. PubMed ID: 15365146
[TBL] [Abstract][Full Text] [Related]
12. Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.
van den Bent MJ; Chinot O; Boogerd W; Bravo Marques J; Taphoorn MJ; Kros JM; van der Rijt CC; Vecht CJ; De Beule N; Baron B
Ann Oncol; 2003 Apr; 14(4):599-602. PubMed ID: 12649108
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy.
Chinot OL; Honore S; Dufour H; Barrie M; Figarella-Branger D; Muracciole X; Braguer D; Martin PM; Grisoli F
J Clin Oncol; 2001 May; 19(9):2449-55. PubMed ID: 11331324
[TBL] [Abstract][Full Text] [Related]
14. Complete durable response of a pediatric anaplastic oligodendroglioma to temozolomide alone: Case report and review of literature.
Sorge C; Li R; Singh S; Reddy AT; Solomon DA; Perry A; Friedman GK
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28696020
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131.
Vogelbaum MA; Berkey B; Peereboom D; Macdonald D; Giannini C; Suh JH; Jenkins R; Herman J; Brown P; Blumenthal DT; Biggs C; Schultz C; Mehta M
Neuro Oncol; 2009 Apr; 11(2):167-75. PubMed ID: 18779504
[TBL] [Abstract][Full Text] [Related]
16. Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma.
Ngo L; Nei M; Glass J
Epilepsia; 2006 Jul; 47(7):1237-8. PubMed ID: 16886989
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
Niwińska A; Rudnicka H; Murawska M
Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of liposomal cytarabine in children with primary CNS tumours with leptomeningeal involvement.
Navajas A; Lassaletta A; Morales A; López-Ibor B; Sábado C; Moscardó C; Mateos E; Molina J; Sagaseta M; Sastre A
Clin Transl Oncol; 2012 Apr; 14(4):280-6. PubMed ID: 22484635
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal chemotherapy for leptomeningeal dissemination of medulloblastoma.
Edwards MS; Levin VA; Seager ML; Wilson CB
Childs Brain; 1981; 8(6):444-51. PubMed ID: 6796342
[TBL] [Abstract][Full Text] [Related]
20. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
Levin VA
Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
